You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 4
  • 416 Elucidating resistance mechanism to parp inhibitors for the development of novel therapeutic approaches in high-grade serous ovarian cancer

Article info

Article menu

Download PDFPDF

Ovarian cancer
416 Elucidating resistance mechanism to parp inhibitors for the development of novel therapeutic approaches in high-grade serous ovarian cancer
Free

Authors

  • Hagen Kulbe Charité Universitätsmedizin Berlin; Department of Gynecology, Campus Virchow Clinic PubMed articlesGoogle scholar articles
  • Wanja Kassuhn Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health PubMed articlesGoogle scholar articles
  • Frauke Ringel Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health PubMed articlesGoogle scholar articles
  • Gabriele Welsch Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health PubMed articlesGoogle scholar articles
  • Peggy Treffkorn Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health PubMed articlesGoogle scholar articles
  • Eliane Taube Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health PubMed articlesGoogle scholar articles
  • David Horst Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health PubMed articlesGoogle scholar articles
  • Jalid Sehouli Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health PubMed articlesGoogle scholar articles
  • Elena Braicu Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health PubMed articlesGoogle scholar articles

Citation

Kulbe H, Kassuhn W, Ringel F, et al
416 Elucidating resistance mechanism to parp inhibitors for the development of novel therapeutic approaches in high-grade serous ovarian cancer
International Journal of Gynecologic Cancer 2020;30:A79.

Publication history

  • First published December 4, 2020.
Online issue publication 
February 04, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.